New research reveals the significant impact severe allergies have on people’s daily lives and mental wellbeing, as well as uncovering an evident lack of awareness about the proper use of adrenaline pens.
Oct 14 2023Reviewed by Lily Ramsey, LLM The research was conducted by Ipsos on behalf of ready2reactuk, a new public awareness campaign supported by UK allergy groups and charities, the British Society for Allergy and Clinical Immunology , Allergy UK, Anaphylaxis UK and The Natasha Allergy Research Foundation, together with, the global healthcare company Viatris.
This is why the ready2reactuk campaign aims to educate patients prescribed adrenaline pens , parents and carers, and the wider community about the correct use of adrenaline pens. However, the new report has found 1 in 4 surveyed people living with severe allergies don’t always carry an adrenaline pen on them and less than half would feel very confident using one in an emergency. Additionally, 68% of those surveyed were not aware of the exact expiry date for their adrenaline pen and 21% didn’t know adrenaline pens have an expiry date.
The ready2reactuk public awareness campaign, funded by Viatris Healthcare UK Ltd., is endorsed by a multidisciplinary steering committee made up of allergy specialists, healthcare professionals, charities, schools, and patients, striving to educate the public about allergies, anaphylaxis, and the use of adrenaline pens.